India has triple advantage of cost, quality and scale in pharma sector: DoP Secretary S Aparna MD Bureau28 April 2022 1:18 PM ISTAs we march ahead and aspire to be a global leader by 2047, differentiation based on innovation will be the key in achieving this objective, she...
Lupin, Yabao Pharma collaborate to meet growing demand for pediatric formulations in China Ruchika Sharma28 April 2022 12:34 PM ISTMumbai: Global pharma major Lupin Limited has announced that the company has entered into a strategic partnership with Yabao Pharmaceutical Co. Inc.,...
Pfizer, Biohaven get European Commission marketing nod for migraine drug Vydura Ruchika Sharma28 April 2022 12:00 PM ISTVYDURA is taken orally as needed, up to once daily, to stop migraine attacks or taken every other day to help prevent migraine attacks.
Lupin ropes in Diana Amador-Toro as Senior Vice President, Global Compliance Ruchika Sharma28 April 2022 11:00 AM ISTDiana Amador-Toro will be based in Lupin's Somerset office in New Jersey, USA.
Syngene Q4 PAT up 7 percent to Rs 148 crore Ruchika Sharma28 April 2022 9:45 AM ISTNew Delhi: Contract manufacturing services firm Syngene International on Wednesday said its profit after tax (PAT), before accounting for exceptional...
Biocon Biologics bags Rs 689 crore contract for Insugen from Malaysian Govt Ruchika Sharma27 April 2022 2:53 PM ISTThe rh-Insulin formulations, Insugen-R, Insugen-N and lnsugen-30/70, are manufactured at Biocon Sdn. Bhd.'s Johor facility.
Andhra Pradesh: VIMS to conduct intranasal COVID vaccine trials Adity Saha27 April 2022 1:02 PM ISTVisakhapatnam: Visakha Institute of Medical Science (VIMS) is one of the ten volunteers and the only institution in Andhra Pradesh to start human...
Gufic Biosciences bags CDSCO approval to manufacture drug for severe fungal infections Ruchika Sharma27 April 2022 12:52 PM ISTIsavuconazole for Injection 200 mg/vial is indicated for the treatment of patients who are 18 years of age and above.
GSK launches single inhaler-triple therapy Trelegy Ellipta to treat COPD in India Ruchika Sharma27 April 2022 11:53 AM ISTTrelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is associated...
Agriculture business drives successful start to year: Bayer Ruchika Sharma27 April 2022 9:00 AM ISTThe CEO reiterated earlier guidance for 2022 core earnings per share to reach about 7.00 euros, up from 6.51 euros last year, excluding the effect of...
Coronavirus vaccine: DCGI grants emergency use nod to Covaxin, Corbevax, ZycovD for different age group of children MD Bureau26 April 2022 5:00 PM ISTDCGI approved restricted use for emergency situation to ZycovD for children above the age of 12 years for a two-dose regimen.
Shilpa Biologicals gets NoC to conduct trials of biosimilar Aflibercept Ruchika Sharma26 April 2022 3:55 PM ISTBiosimilar Aflibercept is the second biosimilar product from SML that has entered the clinical trial phase after Biosimilar Adalimumab.
